Nephropathy
📧 Sign up to get email alerts when something new happens for Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Screening for Fabry Disease in Renal Transplantation
This clinical trial screened renal transplant recipients for Fabry disease; the study (NCT03886714) conducted by University Hospital, Montpe…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: The Role of Ultrasonography in Predicting Outcomes of Fetal Nephropathy
A completed clinical trial evaluating whether ultrasonography can predict outcomes in fetal nephropathy.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Amniotic Biomarkers for the Prediction of Postpartum Renal Function.
A completed clinical trial evaluating whether amniotic biomarkers can predict postpartum renal function in nephropathy.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate [NA]
A prospective randomized trial comparing oral N-Acetylcysteine to intravenous sodium bicarbonate in nephropathy was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study [Phase 1, Phase 2]
A study investigating renal hemodynamics, energetics, and insulin resistance in youth-onset type 2 diabetes, spanning Phase 1 and Phase 2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating copeptin in adolescent participants with type 1 diabetes and early renal hemodynamic changes has compl…
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: Losartan to Reverse Sickle Nephropathy [Phase 2]
A Phase 2 trial evaluating losartan for reversing sickle cell nephropathy has completed enrollment with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial exploring the relationship between homocysteine levels and contrast-induced nephropathy in hypertensive…
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Empagliflozin and Renal Oxygenation in Healthy Volunteers [Phase 2]
Phase 2 clinical trial assessing empagliflozin effects on renal oxygenation in healthy volunteers with nephropathy in the study context.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD) [Phase 4]
A Phase 4 clinical trial update on nighttime losartan in continuous ambulatory peritoneal dialysis for patients with hypertension and nephro…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Nighttime Valsartan in Hemodialysis Hypertension [Phase 4]
Phase 4 clinical trial update examining nighttime valsartan for hypertension in patients undergoing hemodialysis.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA) [Phase 2]
Phase 2 dose-response trial assessing the effect of the aquaretic tolvaptan on the nitric oxide system in nephropathy; the study has complet…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN). [Phase 4]
A Phase 4 randomized trial assessed whether rosuvastatin reduces the risk of contrast-induced nephropathy in patients undergoing elective an…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA) [Phase 2]
Phase 2 trial evaluating the effect of tolvaptan on the nitric oxide system in cardiovascular diseases and nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects [NA]
A completed clinical trial evaluated the effects of thiazide, amiloride, and hypertonic saline on urinary biomarkers in healthy subjects, wi…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects [NA]
The trial assessed the effects of isotonic vs. hypertonic saline infusions on renal biomarkers in healthy young subjects.
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man [Phase 2]
Phase 2 clinical trial update assessing the effects of atorvastatin on the nitric oxide system in healthy young men.